DC.A DUNDEE CORP

Dundee Corporation Announces the Sale of 8,000 Shares of TauRx Pharmaceuticals Ltd. for Proceeds of US$1 Million

Dundee Corporation Announces the Sale of 8,000 Shares of TauRx Pharmaceuticals Ltd. for Proceeds of US$1 Million

TORONTO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.A) (the “Company” or “Dundee”) announced today that it has sold to a private investor 8,000 of the 1,015,008 shares it holds in TauRX Pharmaceuticals Ltd. (“TauRx”) at a price of US$125 per share for proceeds to the Company of US$1,000,000. The transaction remains subject to TauRx board approval. Following the completion of the transaction Dundee will continue to hold 1,007,008 TauRx shares.

ABOUT DUNDEE CORPORATION

Dundee Corporation is a public Canadian independent holding company, listed on the Toronto Stock Exchange under the symbol “DC.A”. Through its operating subsidiaries, Dundee Corporation is an active investor focused on delivering long-term, sustainable value as a trusted partner in the mining sector with more than 30 years of experience making accretive mining investments.

FORWARD-LOOKING STATEMENTS:

This press release may contain forward-looking information within the meaning of applicable securities legislation, which reflects Dundee Corporation’s current expectations regarding future events. Forward-looking information is based on a number of assumptions and is subject to a number of risks and uncertainties, many of which are beyond Dundee Corporation’s control, which could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking information. Such risks and uncertainties include, but are not limited to, the factors discussed under “Risk Factors” in the Annual Information Form of Dundee Corporation and subsequent filings made with securities commissions in Canada. Dundee Corporation does not undertake any obligation to update such forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

FOR FURTHER INFORMATION PLEASE CONTACT:

Investor and Media Relations

T: (416) 864-3584

E:



EN
26/09/2024

Underlying

DC.ADUNDEE CORP

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DUNDEE CORP

 PRESS RELEASE
Free
DC.A DUNDEE CORP

Dundee Corporation Completes Sale of 8,000 Shares of TauRx Pharmaceuti...

Dundee Corporation Completes Sale of 8,000 Shares of TauRx Pharmaceuticals Ltd. for Proceeds of US$1 Million TORONTO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.A) (the “Company” or “Dundee”) announces that further to the news release disseminated on September 26, 2024, it has now received the requisite board approval from TauRX Pharmaceuticals Ltd. (“TauRx”) for the sale of 8,000 shares to a private investor at a price of US$125 per share for proceeds to the Company of US$1,000,000. The transaction has now been completed. Dundee continues to hold 1,007,008 shares of Ta...

October 7, 2024 1 EN
 PRESS RELEASE
Free
DC.A DUNDEE CORP

Dundee Corporation Completes the Redemption of Its Series 2 and Series...

Dundee Corporation Completes the Redemption of Its Series 2 and Series 3 Preference Shares TORONTO, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.A) (“Dundee” or the “Company”) announces that it has now completed the redemption of the 1,145,362 outstanding cumulative 5-year rate reset first preference shares, series 2 (the “Series 2 Preference Shares”) and the 724,982 outstanding cumulative floating rate first preference shares, series 3 (the “Series 3 Preference Shares”). The redemption price of $25.00 per share, together with the accrued and unpaid dividends were paid to...

October 1, 2024 1 EN
 PRESS RELEASE
Free
DC.A DUNDEE CORP

Dundee Corporation Strengthens Commitment to Core Strategy and Announc...

Dundee Corporation Strengthens Commitment to Core Strategy and Announces the Sale of its Investment Management Business TORONTO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.A) (the “Company” or “Dundee”) announced today that, in alignment with its commitment to its core strategic objectives, it has entered into a definitive agreement to sell its investment management business (the “Investment Management Business”) operated through Goodman & Company, Investment Counsel Inc. to Next Edge Capital Corp. (“Next Edge”) (the “Transaction”). The decision to sell the Investment ...

September 30, 2024 1 EN
 PRESS RELEASE
Free
DC.A DUNDEE CORP

Dundee Corporation Announces the Sale of 8,000 Shares of TauRx Pharmac...

Dundee Corporation Announces the Sale of 8,000 Shares of TauRx Pharmaceuticals Ltd. for Proceeds of US$1 Million TORONTO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.A) (the “Company” or “Dundee”) announced today that it has sold to a private investor 8,000 of the 1,015,008 shares it holds in TauRX Pharmaceuticals Ltd. (“TauRx”) at a price of US$125 per share for proceeds to the Company of US$1,000,000. The transaction remains subject to TauRx board approval. Following the completion of the transaction Dundee will continue to hold 1,007,008 TauRx shares. ABOUT DUNDEE C...

September 26, 2024 1 EN
 PRESS RELEASE
Free
DC.A DUNDEE CORP

Dundee Corporation Announces Acquisition of Shares of Maritime Resour...

Dundee Corporation Announces Acquisition of Shares of Maritime Resources Corp. TORONTO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- In accordance with regulatory requirements, Dundee Corporation (TSX: DC.A) (“Dundee”) announces that its wholly owned subsidiary, Dundee Resources Limited, has acquired by private agreement 47,000,000 common shares of Maritime Resources Corp. (TSXV - MAE) (the “Issuer”) at a price of $0.034 per share for aggregate consideration of C$1,598,000. Immediately prior to the acquisition of securities described in this news release, Dundee and its affiliates owned 312,967,1...

September 24, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch